TBC1D3I
gene geneOn this page
Summary
TBC1D3I (TBC1 domain family member 3I, HGNC:32709) is a protein-coding gene on chromosome 17q12, encoding TBC1 domain family member 3I (A0A087WXS9). Acts as a GTPase activating protein for RAB5.
Predicted to enable GTPase activator activity. Predicted to be located in plasma membrane.
Source: NCBI Gene 102724862 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001291463
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32709 |
| Approved symbol | TBC1D3I |
| Name | TBC1 domain family member 3I |
| Location | 17q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000274933 |
| Ensembl biotype | protein_coding |
| Entrez | 102724862 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000616671, ENST00000618620, ENST00000621034
RefSeq mRNA: 1 — MANE Select: NM_001291463
NM_001291463
CCDS: CCDS74039
Canonical transcript exons
ENST00000618421 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 79.78.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.78 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.46 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 76.84 | gold quality |
| left testis | UBERON:0004533 | 74.20 | gold quality |
| testis | UBERON:0000473 | 73.68 | gold quality |
| right testis | UBERON:0004534 | 72.95 | gold quality |
| right uterine tube | UBERON:0001302 | 69.21 | gold quality |
| granulocyte | CL:0000094 | 66.47 | gold quality |
| esophagus mucosa | UBERON:0002469 | 66.08 | gold quality |
| blood | UBERON:0000178 | 65.39 | gold quality |
| stromal cell of endometrium | CL:0002255 | 65.34 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 65.08 | gold quality |
| cerebellum | UBERON:0002037 | 64.23 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 64.07 | gold quality |
| cerebellar cortex | UBERON:0002129 | 63.98 | gold quality |
| adenohypophysis | UBERON:0002196 | 63.76 | gold quality |
| vagina | UBERON:0000996 | 63.22 | gold quality |
| pituitary gland | UBERON:0000007 | 62.93 | gold quality |
| tonsil | UBERON:0002372 | 62.91 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 62.76 | gold quality |
| right lobe of liver | UBERON:0001114 | 62.60 | gold quality |
| endocervix | UBERON:0000458 | 62.32 | gold quality |
| esophagus | UBERON:0001043 | 62.06 | gold quality |
| right adrenal gland | UBERON:0001233 | 62.00 | gold quality |
| prostate gland | UBERON:0002367 | 61.97 | gold quality |
| ectocervix | UBERON:0012249 | 61.85 | gold quality |
| apex of heart | UBERON:0002098 | 61.69 | gold quality |
| left adrenal gland | UBERON:0001234 | 61.47 | gold quality |
| primary visual cortex | UBERON:0002436 | 61.44 | gold quality |
| uterine cervix | UBERON:0000002 | 61.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting TBC1D3I, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-130B-5P | 99.83 | 68.50 | 1888 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-12130 | 99.75 | 65.47 | 452 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-3940-5P | 99.14 | 65.26 | 493 |
| HSA-MIR-4507 | 99.14 | 65.27 | 515 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-8060 | 98.61 | 66.93 | 1187 |
| HSA-MIR-5585-5P | 97.95 | 68.80 | 1024 |
| HSA-MIR-3135A | 96.41 | 65.30 | 494 |
Cross-species orthologs
0 orthologs
Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D13 (ENSG00000107021), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), GRTP1 (ENSG00000139835), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), SGSM1 (ENSG00000167037), TBC1D21 (ENSG00000167139), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3K (ENSG00000273513), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512)
Protein
Protein identifiers
TBC1 domain family member 3I — A0A087WXS9 (reviewed: A0A087WXS9)
All UniProt accessions (2): A0A087WXS9, A0A0B4J2F4
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a GTPase activating protein for RAB5. Does not act on RAB4 or RAB11.
Subcellular location. Cell membrane.
Post-translational modifications. Ubiquitinated by a CUL7-based E3 ligase, which leads to proteasomal degradation. Palmitoylation is required for membrane localization and protects TBC1D3 from ubiquitination.
Miscellaneous. TBC1D3 is encoded by a collection of very similar paralogs with multiple copies of each paralog, some human genomes encoding well over 50 copies depending on ethnic origin of the donor.
RefSeq proteins (1): NP_001278392* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000195 | Rab-GAP-TBC_dom | Domain |
| IPR035969 | Rab-GAP_TBC_sf | Homologous_superfamily |
| IPR050302 | Rab_GAP_TBC_domain | Family |
Pfam: PF00566
UniProt features (7 total): region of interest 2, lipid moiety-binding region 2, chain 1, domain 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A087WXS9-F1 | 60.13 | 0.24 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 318, 325
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 11 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, MIR335_3P, MIR5585_5P, chr17q12, GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY, WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME, GOCC_ENDOSOME, GOMF_GTPASE_ACTIVATOR_ACTIVITY
GO Biological Process (0):
GO Molecular Function (1): GTPase activator activity (GO:0005096)
GO Cellular Component (3): endosome (GO:0005768), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
26 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBC1D3I | TBC1D20 | Q96BZ9 | 166 |
| TBC1D3I | BBS9 | P78514 | 164 |
| TBC1D3I | TBC1D22A | Q8WUA7 | 133 |
| TBC1D3I | TBC1D22B | Q9NU19 | 133 |
| TBC1D3I | ALG3 | Q92685 | 109 |
| TBC1D3I | SARAF | Q96BY9 | 72 |
| TBC1D3I | BIN3 | Q9NQY0 | 72 |
| TBC1D3I | BIN1 | O00499 | 72 |
| TBC1D3I | AMPH | P49418 | 72 |
| TBC1D3I | BIN2 | Q9UBW5 | 72 |
| TBC1D3I | GPR32 | O75388 | 0 |
| TBC1D3I | ERVFRD-1 | P60508 | 0 |
| TBC1D3I | CCDC7 | Q96M83 | 0 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A6NDS4, A6NER0, A6QPT6, B9A6J9, M3WHG5, O14771, O15482, O15553, O19110, O76081, P0C7X1, P0C7X3, P0C7X4, P35125, P48778, P48967, P79209, Q13670, Q15697, Q2TBC4, Q3T191, Q3UZD7, Q4R2Z8, Q5DRQ5, Q5SSQ6, Q5XFX8, Q69ZB3, Q6DHY5, Q6IPX1, Q6ZMN8, Q8BLR5, Q8BWA8, Q8IYF1, Q8IZP1, Q8JZW5, Q8N7G0
Diamond homologs: A0A087WVF3, A0A087WXS9, A0A087X179, A0A087X1G2, A2AWA9, A6H6A9, A6NDS4, A6NER0, B9A6J9, H2KZZ6, P0C7X1, P35125, Q2M2D7, Q5RAN1, Q5SVR0, Q66K14, Q6DHY5, Q6IPX1, Q80XC3, Q86UD7, Q8IZP1, Q92738, Q9UFV1, Q9Y3P9, A3KGB4, A6QP29, B0R0W9, B7ZAP0, O60343, O60447, O95759, O97790, P58802, P97366, Q0IIM8, Q10496, Q12317, Q12344, Q28CB1, Q3UYK3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1156397786 (17:36264585 G>A), RS1158091702 (17:36258681 ACT>A), RS1158209801 (17:36254460 G>A), RS1158468433 (17:36260292 G>A), RS1158805655 (17:36253901 G>A,C), RS1158900733 (17:36258537 G>A), RS1158918147 (17:36257543 G>A), RS1158994273 (17:36257041 G>A), RS1159334106 (17:36254473 A>C), RS1159685156 (17:36258120 GC>G), RS1159928007 (17:36265384 A>G), RS1160083215 (17:36262117 C>T), RS1160665676 (17:36264679 G>T), RS1160830360 (17:36260508 G>T), RS1161516484 (17:36262018 ATGGGCTTCTGGC>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2,3,5-trichloro-6-phenyl-(1,4)benzoquinone | increases expression | 1 |
| Smoke | decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.